Table 2.
Prevalence and analyses of FcaGHV1 DNAemia among patient and control groups.
| Group | FcaGHV1-Infected | FcaGHV1 Negative | Prevalence (%) | Contingency Table Results | |||
|---|---|---|---|---|---|---|---|
| Groups Compared | Fisher’s Exact Test a | RR b | 95% CI c | ||||
| P1 | 1 | 17 | 5.6 | P1 vs. C1 | 1.000 | 0.5556 | 0.07145 to 4.320 |
| C1 | 5 | 53 | 8.6 | ||||
| P2 | 8 | 49 | 14.0 | P2 vs. C2 | 0.5572 | 1.268 | 0.7892 to 2.039 |
| C2 | 5 | 52 | 8.8 | ||||
| P3 | 4 | 1 | 80.0 | P3 vs. C3 | 0.0068 | 5.200 | 2.207 to 12.25 |
| C3 | 6 | 33 | 15.4 | C4 vs. C3 | <0.0001 | 4.643 | 2.119 to 10.17 |
| C4 | 15 | 6 | 71.4 | P3 vs. C4 | 1.000 | 1.120 | 0.6691 to 1.875 |
a p-value results; b RR: relative risk; c 95% CI: 95% confidence interval of RR.